Efficacy, Safety, and Tolerability of Intravenous Gammaglobulin in a Phase 3, Randomized, Placebo-Controlled, Cross-Over Trial for the Treatment of Multifocal Motor Neuropathy (MMN)

March 9, 2012

Speaker: Carol Koski, MD

Friday, April 27, 2012

12:45 p.m. – 1:00 p.m.

Biographical Information:

Dr. Carol Lee Koski is the Medical Director and a member of the medical advisory Board for the Guillain–Barré Syndrome/ Chronic Inflammatory Demyelinating Polyneuropathy Foundation International (GBS/CIDP Foundation International).

She retired from the University School of Medicine in Baltimore in April 2006, where she served as a professor of neurology and director of the Neuromuscular Division and the Physicians Infusion clinic in the Department of Neurology.

Dr. Koski received her medical degree from the University of Maryland School of Medicine. She completed residencies at the University  of Maryland Medical System and Jackson Memorial Hospital in Miami, Florida, and fellowships in neuromuscular disease, neurochemistry, and neuroimmunology at University Hospital in Baltimore; the Eunice Kennedy Shriver Center in Waltham, Massachusetts; and the Neuroimmunology Branch of National Institutes of Health in Bethesda, Maryland, respectively.
Major research interests include complement in Inflammatory neuropathy, ovarian hormones in neuronal survival in central nervous system inflammation, validation of clinical criteria for CIDP as well as outcomes relative to the clinical course and therapy of these patients. She has coauthored numerous book chapters, as well as articles for journals such as Journal of Clinical Investigation, PNAS, Neurology, Annals of Neurology, Glia and Journal of the Peripheral Nervous System. Dr. Koski served on the US Food and Drug Administration panel on CNS and PNS drugs and continues to serve as a consultant.

 email to a friend  |   print